Employee-related Liabilities, Current of Dare Bioscience, Inc. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Dare Bioscience, Inc. quarterly Employee-related Liabilities, Current in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • Dare Bioscience, Inc. Employee-related Liabilities, Current for the quarter ending 31 Dec 2024 was $805,612, a 0.02% increase year-over-year.
Source SEC data
View on sec.gov
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Change (%)

Dare Bioscience, Inc. Quarterly Employee-related Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $805,612 +$200 +0.02% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $805,412 -$915,089 -53% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $1,720,501 +$187,026 +12% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $1,533,475 +$376,401 +33% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $1,157,074 +$441,873 +62% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $715,201 +$298,967 +72% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q4 2018 $416,234 +$100,210 +32% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q4 2017 $316,024 -$763,976 -71% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q2 2017 $44,000 -$1,190,000 -96% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 $146,000 -$603,000 -81% 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 $1,080,000 -$784,000 -42% 31 Dec 2016 10-Q 14 Aug 2017 2017 Q2
Q3 2016 $1,319,000 -$263,000 -17% 30 Sep 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 $1,234,000 +$295,000 +31% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 $749,000 +$247,000 +49% 31 Mar 2016 10-Q 02 May 2016 2016 Q1
Q4 2015 $1,864,000 +$881,000 +90% 31 Dec 2015 10-K/A 13 Jun 2017 2016 FY
Q3 2015 $1,582,000 +$896,000 +131% 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 $939,000 +$455,000 +94% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 $502,000 +$283,000 +129% 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 $983,000 +$365,000 +59% 31 Dec 2014 10-K 10 Mar 2016 2015 FY
Q3 2014 $686,000 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 $484,000 30 Jun 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 $219,000 31 Mar 2014 10-Q 27 May 2014 2014 Q1
Q4 2013 $618,000 31 Dec 2013 10-K 19 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.